Clinical applications of cardiac magnetic resonance imaging

Minerva Cardioangiologica

Volumn 57, Issue 3, 2009, Pages 299-313

  Pilz, G ^a,b   Heer, T ^a   Harrer, E ^a   Ali, E ^a   Hoefling, B ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Heart function tests; Heart valve diseases; Magnetic resonance imaging; Myocardial ischemia; Myocarditis; Ventricular function, left

Indexed keywords

GADOLINIUM;

ANATOMY; ANGIOCARDIOGRAPHY; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; COMPETENCE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HEART MUSCLE PERFUSION; HEART VENTRICLE FUNCTION; HUMAN; IMAGE ENHANCEMENT; IONIZING RADIATION; MYOCARDITIS; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVIEW; TRANSTHORACIC ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE;

CARDIOMYOPATHIES; CONTRAST MEDIA; CORONARY ARTERY DISEASE; DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; GADOLINIUM; HEART DEFECTS, CONGENITAL; HEART FUNCTION TESTS; HEART VALVE DISEASES; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA; MYOCARDITIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VENTRICULAR FUNCTION, LEFT;

EID: 69649103549     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademakers FE et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 2004;25:1940-1965.
2. Bellenger NG, Burgess MI, Ray SG, Lahiri A, Coats AJ, Cleland JG et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance: are they interchangeable. Eur Heart J 2000;21:1387-1396 (Pubitemid 30599134)
3. Grothues F, Smith GC, Moon JCC, Bellenger NG, Collins P, Klein HU et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal sujects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002;90:29-34. (Pubitemid 34671198)
4. Mogelvang J, Lindvig K, Sondergaard L, Saunamäki K, Henriksen O et al. Reproducibility of cardiac volume measurements including left ventricular mass determined by MRI. Clin Physiol 1993;13:587-597 (Pubitemid 23338310)
5. Bellenger NG, Davies LC, Francis JM, Coats AJ, Pennell DJ. Reduction in sample size for studies of remodelling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2000;2:271-278
6. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002. (Pubitemid 29529292)
7. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 2004;43:2253-2259 (Pubitemid 38757594)
8. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006;113;2733-2743 (Pubitemid 43947991)
9. Schulz-Menger J, Gross M, Messroghli D, Uhlich F, Dietz R, Friedrich MG. Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. J Am Coll Cardiol 2003;42:513-518 (Pubitemid 36951720)
10. Assomull RG, Lyne JC, Keenan N, Gulati A, Bunce NH, Davies SW et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J 2007;28:1242-1249 (Pubitemid 47343853)
11. Pilz G, Bernhardt P, Harrer E, Klos M, Höfling B. Cardiac magnetic resonance imaging - an essential diagnostic aid in suspected myocardial re-infarction in a 40 year old woman. Clin Res Cardiol 2008;97:280-283
12. Abdel-Aty H, Boyé P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis. J Am Coll Cardiol 2005;45:1815-1822
13. Laissy JP, Hyafil F, Feldman LJ, Juliard JM, Schouman-Claeys E, Steg PG et al. Differentiating acute myocardial infarction from myocarditis: diagnostic value of early and delayed perfusion cardiac MR imaging. Radiology 2005;237:75-82. (Pubitemid 41346148)
14. Ichikawa Y, Sakum H, Suzawa N, Kitagawa K, Makino K, Hirano T et al. Late gadolinium-enhanced magnetic resonance imaging in acute and chronic myocardial infarction. J Am Coll Cardiol 2005;45:901-909
15. Beek AM, Kühl HP, Bondarenko O, Twisk JW, Hofman MB, van Dockum WG et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol 2003;42:895-901. (Pubitemid 37059750)
16. Krittayaphong R, Laksanabunsong P, Maneesai A, Saiviroonporn P, Udompunturak S et al. Comparison of cardiovascular magnetic resonance of late gadolinium enhancement and diastolic wall thickness to predict recovery of left ventricular function after coronary artery bypass surgery. J Cardiovasc Magn Reson 2008;10:41.
17. Wu KC. Fighting the "Fire" of myocardial reperfusion injury: how to define success? J Am Coll Cardiol 2009;53:730-731
18. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-379 (Pubitemid 36164969)
19. Mahrholdt H, Wagner A, Parker M, Regenfus M, Fieno DS, Bonow RO et al. Relationship of contractile function to transmural extent of infarction in patients with chronic coronary artery disease. J Am Coll Cardiol 2003;42:505-512 (Pubitemid 36951719)
20. Arai AE. False positive or true positive troponin in patients presenting with chest pain but "normal" coronary arteries: lessons from cardiac MRI. Eur Heart J 2007;28:1175-1177
21. Bellenger NG, Peebles C, Harden S, Dawkins K, Curzen N. Troponin positive chest pain with unobstructed coronary arteries: a role for delayed enhanced cardiovascular magnetic resonance in the diagnosis of non-ST elevation myocardial infarction. J Cardiovasc Magn Reson 2007;9:159-160
22. Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos RC. Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease. A meta-analysis. J Am Coll Cardiol 2007;50:1343-1353 (Pubitemid 47449733)
23. Pennell DJ, Underwood SR, Ell PJ, Swanton RH, Walker JM, Longmore DB. Dipyridamole magnetic resonance imaging: a comparison with thallium-201 emission tomography. Br Heart J 1990;64:362-369
24. Casolo GC, Bonechi F, Taddei T, Fortini A, Dabizzi RP, Bisi G et al. Alterations in dipyridamole induced LV wall motion during myocardial ischaemia studied by NMR imaging. Comparison with Tc-99m-MIBI myocardial scintigraphy. G Ital Cardiol 1991;21:609-617
25. Al-Saadi N, Nagel E, Gross M, Bornstedt A, Schnackenburg B, Klein C et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 2000;101:1379-1383
26. Cury RC, Cattani CA, Gabure LA, Racy DJ, de Gois JM, Siebert U et al. Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease. Radiology 2006;240:39-45. (Pubitemid 43902593)
27. Giang TH, Nanz D, Coulden R, Friedrich M, Graves M, Al-Saadi N et al. Detection of coronary artery disease by magnetic resonance myocardial perfusion imaging with various contrast medium doses: first European multi-centre experience. Eur Heart J 2004;25:1657-1665 (Pubitemid 39209287)
28. Klem I, Heitner JF, Shah DJ, Sketch MH Jr, Behar V, Weinsaft J et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol 2006;47:1630-1638
29. Pilz G, Bernhardt P, Klos M, Ali E, Wild M, Höfling B. Clinical implication of adenosine-stress cardiac magnetic resonance imaging as potential gatekeeper prior to invasive examination in patients with AHA/ACC class II indication for coronary angiography. Clin Res Cardiol 2006;95:531-538 (Pubitemid 44496717)
30. Plein S, Radjenovic A, Ridgway JP, Barmby D, Greenwood JP, Ball SG,et al. Coronary artery disease: myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography. Radiology 2005;235:423-430
31. Rieber J, Huber A, Erhard I, Mueller S, Schweyer M, Koenig A et al. Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve. Eur Heart J 2006;27:1465-1471 (Pubitemid 43998081)
32. Thiele H, Plein S, Breeuwer M, Ridgway JP, Higgins D, Thorley PJ et al. Color-encoded semiautomatic analysis of multi-slice first-pass magnetic resonance perfusion: comparison to tetrofosmin single photon emission computed tomography perfusion and X-ray angiography. Int J Cardiovasc Imaging 2004;20:371-384 (Pubitemid 39303212)
33. Nagel E, Klein C, Paetsch I, Hettwer S, Schnackenburg B, Wegscheider K et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 2003;108:432-437 (Pubitemid 36935536)
34. Plein S, Greenwood JP, Ridgway JP, Cranny G, Ball SG, Sivananthan MU. Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J Am Coll Cardiol 2004;44:2173-2181 (Pubitemid 39576037)
35. Bernhardt P, Steffens M, Kleinertz K, Morell R, Budde R, Leischik R et al. Safety of adenosine stress magnetic resonance using a mobile cardiac magnetic resonance system. J Cardiovasc Magn Reson 2006;8:475-478
36. Schwitter J, Nanz D, Kneifel S, Bertschinger K, Büchi M, Knüsel PR et al. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance - a comparison with positron emission tomography and coronary angiography. Circulation 2001;103:2230-2235 (Pubitemid 32433710)
37. Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al-Saadi N, Ahlstrom H et al. MR-IMPACT: comparison of perfusion -cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 2008;29:480-489 (Pubitemid 351264187)
38. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346:1948-1953 (Pubitemid 34651354)
39. Pilz G, Klos M, Ali E, Hoefling B, Scheck R, Bernhardt P. Angiographic correlations of patients with small vessel disease diagnosed by adenosine-stress cardiac magnetic resonance imaging. J Cardiovasc Magn Reson 2008;10:8.
40. Paetsch I, Jahnke C, Wahl A, Gebker R, Neuss M, Fleck E, et al. Comparison of dobutamine stress magnetic resonance adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation 2004;110:835-842 (Pubitemid 39096012)
41. Paetsch I, Jahnke C, Ferrari VA, Rademakers FE, Pellikka PA, Hundley WG et al. Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging. Eur Heart J 2006;27:1459-1464 (Pubitemid 43998080)
42. Nagel E, Lehmkuhl H, Bocksch W, Klein C, Vogel U, Frantz E et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999;99:763-770 (Pubitemid 29083016)
43. Nagel E, Lehmkuhl HB, Klein C, Schneider U, Frantz E, Ellmer A et al. Influence of image quality on the diagnostic accuracy of dobutamine stress magnetic resonance imaging in comparison with dobutamine stress echocardiography for the non-invasive detection of myocardial ischemia. Z Kardiol 1999;88:622-630 (Pubitemid 29472684)
44. Pingitore A, Lombardi M, Scattini B, De Marchi D, Aquaro GD, Positano V et al. Head to head comparison between perfusion and function during accerlerated high-dose dipyridamole magnetic resonance stress for the detection of coronary artery disease. Am J Cardiol 2008;101:8-14. (Pubitemid 350297197)
45. Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 2004;11:171-185 (Pubitemid 38949912)
46. Hundley WG, Morgan TM, Neagle CM, Hamilton CA, Rerkpattanapipat P, Link KM. Magnetic resonance imaging determination of cardiac prognosis. Circulation 2002;106:2328-2333 (Pubitemid 35244733)
47. Ingkanisorn WP, Kwong RY, Bohme NS, Geller NL, Rhoads KL, Dyke CK et al. Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol 2006;47:1427-1432
48. Jahnke C, Nagel E, Gebker R, Kokocinski T, Kelle S, Manka R et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 2007;115:1769-1776 (Pubitemid 46648614)
49. Nagel E, Lorenz C, Baer F, Hundley WG, Wilke N, Neubauer S et al. Stress cardiovascular magnetic resonance: consensus panel report. J Cardiovasc Magn Reson 2001;3:267-281 (Pubitemid 33062631)
50. Pilz G, Jeske A, Klos M, Ali E, Hoefling B, Scheck R et al. Prognostic value of normal adenosine-stress cardiac magnetic resonance imaging. Am J Cardiol 2008;101:1408-1412
51. Madsen J, Bech J, Jørgensen E, Kastrup J, Kelbaek H, Saunamäki K. Yield of 5,536 diagnostic coronary arteriographies: Results from a data registry. Cardiology 2002;98:191-194 (Pubitemid 36091856)
52. Zeymer U, Zahn R, Hochadel M,, Bonzel T, Weber M, Gottwik M et al. Indications and complications of invasive diagnostic procedures and percutaneous coronary interventions in the year 2003. Results of the quality control registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausä rzte (ALKK). Z Kardiol 2005;94:392-398
53. Høilund-Carlsen P, Johansen A, Christensen H, Vach W, Møldrup M, Bartram P et al. Potential impact of myocardial perfusion scintigraphy as gatekeeper for invasive examination and treatment in patients with stable angina pectoris: observational study without post-test referral bias. Eur Heart J 2006;27:29-34. (Pubitemid 41785929)
54. Shaw LJ, Hachamovitch R, Berman DS, Marwick TH, Lauer MS, Heller GV et al.; for the Economics of Noninvasive Diagnosis (END) Multicenter Study Group. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. J Am Coll Cardiol 1999;33:661-669
55. McConnell MV, Ganz P, Selwyn AP, Li W, Edelman RR, Manning WJ. Identification of anomalous coronary arteries and their anatomic course by magnetic resonance coronary angiography. Circulation 1995;92:3158-3162
56. Post JC, van Rossum AC, Bronzwaer JG, de Cock CC, Hofman MB, Valk J et al. Magnetic resonance angiography of anomalous coronary arteries: a new gold standard for delineating the proximal course? Circulation 1995;92:3163-3171
57. Pouleur A-C, le Polain de Waroux J-B, Kefer J, Pasquet A, Vanoverschelde J-L, Gerber Bernhard L. Direct comparison of whole-heart navigator-gated magnetic resonance coronary angiography and 40- and 64-slice multidetector row computed tomography to detect the coronary artery stenosis in patients scheduled for conventional coronary angiography. Circ Cardiovasc Imaging 2008;1:114-121
58. Bluemke DA, Achenbach S, Budoff M, Budoff M, Gerber TC, Gersh B, Hillis LD et al. Noninvasive Coronary Artery Imaging Magnetic Resonance Angiography and Multidetector Computed Tomography Angiography. A Scientific Statement From the American Heart Association Committee on Cardio-vascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention, and the Councils on Clinical Cardiology and Cardiovascular Disease in the Young. Circulation 2008;118:586-606.
59. Kim WY, Danias PG, Stuber M, Flamm SD, Plein S, Nagel E et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 2001;345:1863-1869 (Pubitemid 33716560)
60. Huber A, Nikolaou K, Gonschior P, Knez A, Stehling M, Reiser M. Navigator echo-based respiratory gating for three-dimensional MR coronary angiography: results from healthy volunteers and patients with proximal coronary artery stenoses. Am J Roentgenol 1999;173:95-101. (Pubitemid 29291097)
61. Klein C, Gebker R, Kokocinski T, Dreysse S, Schnackenburg B, Fleck E et al. Combined magnetic resonance coronary artery imaging, myocardial perfusion and late gadolinium enhancement in patients with suspected coronary artery disease. J Cardiovasc Magn Res 2008;10:45.
62. Sakuma H, Ichikawa Y, Chino S, Hirano T, Makino K, Takeda K. Detection of coronary artery stenosis with whole-heart coronary magnetic resonance angiography. J Am Coll Cardiol 2006;48:1946-1950 (Pubitemid 44738453)
63. Kwong RY, Schussheim AE, Rekhraj S, Aletras AH, Geller N, Davis J et al. Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation 2003;107:531-537 (Pubitemid 36176800)
64. Wu KC, Kim RJ, Bluemke DA, Rochitte CE, Zerhouni EA, Becker LC et al. Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol 1998;32:1756-1764
65. Rochitte CE, Lima JA, Bluemke DA, Reeder SB, McVeigh ER, Furuta T et al. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 1998;98:1006-1014 (Pubitemid 28446654)
66. Gerber BL, Rochitte CE, Melin JA, , McVeigh ER, Bluemke DA, Wu KC et al. Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation 2000;101:2734-2741 (Pubitemid 30390578)
67. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-772
68. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001;104:1101-1107 (Pubitemid 32830391)
69. Sechtem U, Pflugfelder P, Cassidy MC, Holt W, Wolfe C, Higgins CB. Ventricular septal defect: visualization of shunt flow and determination of shunt size by cine MR imaging. Am J Roentgenol 1987;149:689-692 (Pubitemid 17155298)
70. Mollet NR, Dymarkowski S, Volders W, Wathiong J, Herbots L, Rademakers FE et al. Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation 2002;106:2873-2876 (Pubitemid 35424733)
71. Skouri HN, Dec W, Friedrich MG, Cooper LT. Noninvasive imaging in myocarditis. J Am Coll Cardiol 2006;48:2085-2093
72. Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802-1809 (Pubitemid 28213624)
73. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H et al. Cardiovascular magnetic resonance assessment of human myocarditis. Circulation 2004;109:1250-1258
74. Benjelloun H, Cranney GB, Kirk KA, Blackwell GG, Lotan CS, Pohost GM. Interstudy reproducibility of biplane cine nuclear magnetic resonance measurements of left ventricular function. Am J Cardiol 1991;67:1413-1420
75. Kasper EK, Agema WR, Hutchins GM, Deckers JW, Hare JM, Baughman KL. The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 1994;23:586-590
76. MacGowan GA, Shapiro EP, Azhari H, Siu CO, Hees PS, Hutchins GM et al. Noninvasive measurement of shortening in the fiber and cross-fiber directions in the normal human left ventricle and in idiopathic dilated cardiomyopathy. Circulation 1997;96:535-541 (Pubitemid 27329430)
77. Fujita N, Duerinekx AJ, Higgins CB. Variation in left ventricular regional wall stress with cine magnetic resonance imaging: normal subjects versus dilated cardiomyopathy. Am Heart J 1993;125:1337-1345 (Pubitemid 23134539)
78. Reichek N. MRI myocardial tagging. J Magn Reson Imaging 1999;10:609-616
79. White RD, Obuchowski NA, Gunawardena S, Lipchik EO, Lever HM, Van Dyke CW et al. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: presurgical and postsurgical evaluation by computed tomography magnetic resonance imaging. Am J Card Imaging 1996;10:1-13. (Pubitemid 26059630)
80. Franke A, Schondube FA, Kuhl HP, Klues HG, Erena C, Messmer BJ et al. Quantitative assessment of the operative results after extended myectomy and surgical reconstruction of the subvalvular mitral apparatus in hypertrophic obstructive cardiomyopathy using dynamic three-dimensional transesophageal echocardiography. J Am Coll Cardiol 1998;31:1641-1649 (Pubitemid 28273310)
81. Schulz-Menger J, Strohm O, Waigand J, Uhlich F, Dietz R, Friedrich MG. The value of magnetic resonance imaging of the left ventricular outflow tract in patients with hypertrophic obstructive cardiomyopathy after septal artery embolization. Circulation 2000;101:1764-1766 (Pubitemid 30213095)
82. Blake LM, Scheinman MM, Higgins CB. MR features of arrhythmogenic right ventricular dysplasia. Am J Roentgenol 1994;162:809-812 (Pubitemid 24115860)
83. Ricci C, Longo R, Pagnan L, Dalla Palma L, Pinamonti B, Camerini F et al. Magnetic resonance imaging in right ventricular dysplasia. Am J Cardiol 1992;70:1589-1595 (Pubitemid 23006073)
84. Seltzer S, Mark AS, Atlas SW. CNS sarcoidosis: evaluation with contrast-enhanced MR imaging. Am J Neuroradiol 1991;12:1227-1233
85. Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance J Cardiovasc Magn Reson 2008;10:42.
86. Fattori R, Rocchi G, Celletti F, Bertaccini P, Rapezzi C, Gavelli G. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy. Am Heart J 1998;136:824-830 (Pubitemid 28506882)
87. Pohost GM, Hung L, Doyle M. Clinical use of cardiovascular magnetic resonance. Circulation 2003;108:647-653 (Pubitemid 36999244)
88. Kizilbash AM, Hundley WG, Willett DL, Franco F, Peshock RM, Grayburn PA. Comparison of quantitative Doppler with magnetic resonance imaging for assessment of the severity of mitral regurgitation. Am J Cardiol 1998;81:792-794 (Pubitemid 28146463)
89. Kozerke S, Schwitter J, Pedersen EM, Boesiger P. Aortic and mitral regurgitation: Quantification using moving slice velocity mapping. J Magn Reson Imaging 2001;14:106-112 (Pubitemid 32709468)
90. Chan KMJ, Wage R, Symmonds K et al. Towards comprehensive assessment of mitral regurgitation using cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008;10:61.
91. John AS, MD, Dill T, Brandt RR, Rau M, Ricken W, Bachmann G et al. Magnetic Resonance to Assess the Aortic Valve Area in Aortic Stenosis. How Does it Compare to Current Diagnostic Standards? J Am Coll Cardiol 2003;42:519-526
92. Djavidani B, Debl K, Lenhart M, Seitz J, Paetzel C, Schmid FX et al. Planimetry of mitral valve stenosis by magnetic resonance imaging. J Am Coll Cardiol 2005;45:2048-2053 (Pubitemid 40814130)
93. Edwards MB, Taylor KM, Shellock FG. Prosthetic heart valves: evaluation of magnetic field interactions, heating, and artifacts at 1.5 T. J Magn Reson Imaging 2000;12:363-369
94. Kozerke S, Hasenkam JM, Nygaard H, Paulsen PK, Pedersen EM, Boesiger P. Heart motion-adapted MR velocity mapping of blood velocity distribution downstream of aortic valve prostheses: initial experience. Radiology 2001;218:548-555 (Pubitemid 32121074)
95. Evenepoel P, Zeegers M, Segaert S, Claes K, Kuypers D, Maes B et al. Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure. Nephrol Dial Transplant 2004;49:469-473 (Pubitemid 38196001)
96. Marckmann P, Skov L, Rossen K, Dupont A, Damholt MB, Heaf JG et al. Nephrogenic systemic fibrosis: Suspected etiological role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006;17:2359-2362 (Pubitemid 44300951)
97. Yuan C, Beach KW, Smith LH Jr, Hatsukami TS. Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation 1998;98:2666-2671 (Pubitemid 28564000)
98. Kim WY, Stuber M, Bornert P, Kissinger KV, Manning WJ, Botnar RM. Kissinger KV, Manning WJ, Botnar RM. Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with non-significant coronary artery disease. Circulation 2002;106:296-299 (Pubitemid 34778950)
99. Kim RJ, de Roos A, Fleck E, Higgins CB, Pohost GM, Prince M et al. Guidelines for training in cardiovascular magnetic resonance (CMR). J Cardiovasc Magn Reson 2007;9:3-4. (Pubitemid 46018477)